Tratamiento de la fibromialgia

Revista Espanola de Reumatologia

Volumn 27, Issue 10, 2000, Pages 442-446

  Fernández Rodríguez, María Antonia ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18944382218     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Reilly PA. How should we manage fibromyalgia? Ann Rheum Dis 1999; 58: 325-6.
2. White KP, Harth M. An analytical review of 24 controlled clinical trial for fibromyalgia syndrome. Pain 1996; 64: 211-9.
3. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39; 1852-9.
4. Johnson SP. Fluoxetina and amitryptine in the treatment of fibromyalgia. J Fam Pract 1997; 44: 128-30.
5. Ataoglu S, Ataoglu A, Erdogan F, Sarac J. Comparison of paroxetina, amitriptyline in the treatment of fibromyalgia. Turk J M Sci 1997; 27: 535-9.
6. Heymann RE, Quaresma M, Helfenstein M, Feldman D. A double blinded, randomized, controlled study between amitriptyline, norytriptyline and placebo in patients with fibromyalgia: analysis of the outcome measures. Rev Bras Reumatol 1998; 38: 119-27.
7. Ginsberg F, Joss E, Geczy J, Bruhwyler J, Vandekerckhove K, Farmaey JP. A pilot randomized placebo-controlled study of pirlindole in the treatment of primary fibromyalgia. J Musculoskeletal Pain 1998; 6: 5-17.
8. Yavuzer G, Kücükdeveci A, Arasil T, Elhan A. Moclobemid treatment in primary fibromyalgia syndrome. Eur J Phys Med Rehabil 1998; 8: 35-8.
9. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptiline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol 1998; 37: 1279-86.
10. Olin R, Klein R, Berg A. A randomised double-blind 16 week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids. Clin Rheumatol 1998; 17: 89-94.
11. Quijada-Carrera J, Valenzuela A, Povedano J, Fernández AM, Hernanz W, Gutiérrez A et al. Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double blind, placebo-controlled trial. Pain 1996; 65: 221-5.
12. Russell IJ, Kamin M, Sager D, Bennett RM, Schnitzer T, Green JA et al. Efficacy of Ultram (tramadol HCI) treatment of fibromyalgia syndrome: preliminary analysis of a multi-center, randomized, placebo-controlled study [resumen]. Arthritis Rheum 1997; 40 (Supl): 117.
13. Russell IJ. Efficacy of ULTRAM (tramadol HCI) treatment of fibromyalgia syndrome (EMS): secondary outcomes report. TPS-FM Study Group [resumen]. J Musculoskel Pain 1998; 6 (Supl 2): 147.
14. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998; 18: 13-9.
15. Ang D. Diagnosis, etiology, and therapy of fibromyalgia. Compr Ther 1999; 25: 221-7.
16. Leal-Cerro A, Povedano J, Astorga R, González M, Silva H, García-Pesquera F et al. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab 1999; 84: 3378-81.
17. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998; 104: 227-31.
18. Breau LM, McGrath PJ, Ju LH. Review of juvenile primary fibromyalgia and chronic fatigue syndrome. J Dev Behav Pediatr 1999; 20: 278-88
19. Fitzcharles MA, Esdaile JM. Nonphysician practitioner treatment and fibromyalgia syndrome. J Rheumatol 1997; 24: 937-40.
20. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective en the treatment of fibromyalgia? Fam Pract 1999; 48: 213-8.
21. Koenig C, Stevermer J. Acupuncture en the treatment of fibromyalgia. J Fam Pract 1999; 48: 497.
22. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupuncture in fibromyalgia: results of a controlled trial. Br Med J 1992; 305: 1249-52.
23. Sim J, Adams N. Physical and other non-pharmacological interventions for fibromyalgia. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 507-23.
24. Ramsay C, Moreland J, Ho M, Joyce S, Walker S, Pullar T. An observer-blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology 2000; 39: 501-5.
25. Ferraccioli G, Ghirelli L, Scrita F, Nolli M, Mozzani M, Fontana S et al. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 1987; 14: 820-25.
26. Blunt KL, Rajwani MH, Guerriero RC, The effectiveness of clinopractic management of fibromyalgia patients: a pilot study. J Manipulative Physiol Ther 1997; 20: 389-99.
27. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain 1999; 3: 235-44.
28. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 1999; 21: 180-91.
29. Bennett RM, Burckhadt CS, Clark SR, O'Reilly CA, Wiens AN, Campbell SM. Group treatment of fibromyalgia: a 6 month outpatient program. J Rheumatol 1996; 23: 521-8.
30. Turk DC, Okifuji A, Sinclair JD, Starz TW. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res 1998; 11: 86-95.
31. Turk DC, Okifuji A, Sinclair JD, Starz TW. Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 1998; 11: 397-404.
32. Mason LW, Goolkasian P, MacCain GA. Evaluation of multimodal treatment program for fibromyalgia. J Behav Med 1998; 21: 163-78.